Enanta Pharmaceuticals, Inc. (ENTA)
14.75
+1.26
(+9.34%)
USD |
NASDAQ |
Feb 24, 16:00
14.60
-0.15
(-1.02%)
After-Hours: 20:00
Enanta Pharmaceuticals Shareholders Equity (Annual) : 64.72M for Sept. 30, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Agios Pharmaceuticals, Inc. | 1.193B |
| ACADIA Pharmaceuticals, Inc. | 732.79M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 171.45M |
| BioMarin Pharmaceutical, Inc. | 6.087B |